Transpharmation at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Transpharmation brings 5 presentations to SfN 2026 in Washington, and exhibits at Booth 717. Its SfN 2026 presentations centre on drug effects in depression and substance use, and on mouse models of sleep and behavior. One thread explores whether GLP-1 receptor agonism produces antidepressant-like activity in a translational mouse model of depression.

OrganizationSfN 2026 Attendance
Transpharmation
Fergus, Canada
transpharmation.com
Contract research and service companies
Preclinical neuroscience contract research organization offering translational drug discovery studies.
Booth
Exhibiting at Booth 717
Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm
Poster
Sun Nov 15
1–5pm
Poster
Sun Nov 15
1–5pm
Poster
Sun Nov 15
1–5pm
Poster
Wed Nov 18
1–5pm
Poster
Wed Nov 18
1–5pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Transpharmation

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction